Touching Base

Episode 2 (December 22, 2023): Interview with President and CEO of Tome Biosciences, Rahul Kakkar; intelligent lab partner using LLMs; AI for antimicrobials; mRNA vaccine production in Africa; Moderna’s positive cancer vaccine data.Listed below are key references to the GEN stories, media and other items discussed in this episode of Touching Base:The Next Chapter in Genome Editing? Tome Emerges from Stealth with $213M By Alex Philippidis, GEN, December 19, 2023.Artificial Intelligence-Based Lab Partner Designs, Runs Experiments in the Lab GEN, December 20, 2023.BioNTech Advances Plans for mRNA Vaccine Production in Africa by 2025 GEN, December 19, 2023.Explainable AI Directs Small Molecule Structural Class Drug Discovery By Jonathan Grinstein, GEN, December 20, 2023.StockWatch: Positive Cancer Vaccine Data Wows Moderna Investors By Alex Philippidis, GEN Edge, December 18, 2023. Hosted on Acast. See acast.com/privacy for more information.

Episode 1 (Week ending December 8, 2023): Nevan Krogan (UCSF) mapping autism pathways; Nvidia’s latest AI partnership; CAR-T regulations; epigenome editing; mRNA therapeutics.References to the GEN stories, media and other items discussed in this episode of Touching Base:·        Autism’s Molecular Mechanisms Uncovered through Protein-Protein Interaction NetworkBy Julianna Lemieux, GEN, December 5, 2023.·        Rhapsody in B: Tune Therapeutics Presents Data for Hepatitis B Epigenetic SilencerBy Jonathan Grinstein, GEN Edge, December 6, 2023.·        Nvidia Looks to Genentech for its Next Leap in AI Drug DiscoveryBy Alex Philippidis, GEN Edge, November 28, 2023.·        StockWatch: CAR-T Shares Mostly Flat as FDA Probes Risk of New CancersBy Alex Philippidis, GEN, December 1, 2023·        Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning {VIDEO}GEN Edge, August 30, 2023·        Press release: John Crowley appointed President & CEO of BIOBiotechnology Innovation Organization·        BIO CEO Rachel King Outlines Industry’s Challenges on “Close to the Edge”GEN multimedia, April 26, 2023 ·        The First CRISPR Drug: Vertex Pharmaceuticals’ Casgevy Wins U.K. Approval for Sickle Cell DiseaseGEN, November 16, 2023 Hosted on Acast. See acast.com/privacy for more information.